Table 3 Details of the samples used in this study, with the clinical presentations at the time of collection
| Â | Sample ID | Age | Sex | Days of illness (chikungunya) | Fever | Arthralgia | Rashes |
|---|---|---|---|---|---|---|---|
Control samples | |||||||
1 | 4915 | 20 | Female | N/A | No | No | No |
2 | 5308 | 20 | Male | N/A | No | No | No |
3 | 4917 | 40 | Female | N/A | No | No | No |
4 | 5444 | 32 | Female | N/A | No | No | No |
Chikungunya infected patient samples (IgM and PCR positive) | |||||||
1 | V-10 4706 | 63 | Male | 7 | Positive | Positive | No |
2 | V-10 4669 | 53 | Female | 7 | Positive | Positive | No |
3 | V-10 4663 | 28 | Female | 6 | Positive | Positive | No |
4 | V-10 4696 | 45 | Female | 5 | Positive | Positive | No |
5 | V-10 4629 | 45 | Male | 7 | Positive | No | No |